Lydia Frick | Director Market Access
Kintiga

Dr. Lydia Frick is Director Market Access at Kintiga, a leading strategic consultancy with deep local expertise and global reach, combining energy and expertise to create seamless, impactful solutions that transform patient access across Europe. As a psychologist, natural scientist, and market access expert, Lydia brings a unique blend of scientific rigor and strategic insight to her work. She combines a deep understanding of clinical evidence generation with a nuanced perspective on the needs and expectations of developers, HTA bodies, and payers. Lydia has led numerous strategic initiatives across orphan and non-orphan therapeutic areas. Her work spans early advice with the G-BA in Germany and EU HTA Joint Scientific Consultations, full-spectrum market access strategy, HTA submissions, stakeholder engagement, and price negotiation support. As a member of key industry associations, Lydia contributes to shaping market access and reimbursement policy at both national and European levels. A passionate advocate for innovation, Lydia leads Kintiga’s AI and automation initiatives. She spearheaded the development of the Endpoint Result Interpreter (EPRI)—a proprietary tool that uses large language models to transform clinical data into precise, submission-ready narratives. This managed interpretive writing service helps pharmaceutical companies meet HTA submission deadlines with the required speed and accuracy.